Ibuprofen 125mg, acetaminophen 250mg; caplets. Avoid other acetaminophen-containing products or pain relievers. Increased risk of GI bleed with anticoagulants, corticosteroids, other OTC or Rx ...
Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, ...
Mounjaro was approved by the Food and Drug Administration (FDA) in May and, while not rising to the level of game-changer, it’s a first-of-its-kind dual-action medication that stimulates both ...
Boehringer Ingelheim has said it will take its obesity drug candidate survodutide into a phase 3 programme later this year. The glucagon/GLP-1 receptor dual agonist – partnered with Zealand ...
This drug is recommended for relieving itching ... reduces inflammation and suppresses immune responses. This dual-action ...
Consequently, dual-drug ADCs, which incorporate multiple agents with different mechanisms of action, represent a promising approach for the development of next-generation therapies. CanWell Pharma ...